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TRPV1 channels are critical brain inflammation
detectors and neuropathic pain biomarkers in mice
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The capsaicin receptor TRPV1 has been widely characterized in the sensory system as a key
component of pain and inflammation. A large amount of evidence shows that TRPV1 is also
functional in the brain although its role is still debated. Here we report that TRPV1 is highly
expressed in microglial cells rather than neurons of the anterior cingulate cortex and other
brain areas. We found that stimulation of microglial TRPV1 controls cortical microglia
activation per se and indirectly enhances glutamatergic transmission in neurons by promoting
extracellular microglial microvesicles shedding. Conversely, in the cortex of mice suffering
from neuropathic pain, TRPV1 is also present in neurons affecting their intrinsic electrical
properties and synaptic strength. Altogether, these findings identify brain TRPV1 as potential
detector of harmful stimuli and a key player of microglia to neuron communication.
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T
he transient receptor potential vanilloid type 1 (TRPV1),
also known as vanilloid receptor, is a non-selective cationic
channel that is exogenously activated by capsaicin, resinifer-
atoxin and some venom toxin1–3. Endogenously, TRPV1 is
opened by high temperatures (443 C), acid pH, anandamide
(N-arachidonoylethanolamine), 2-arachidonoylglycerol, N-arachi-
donoyl dopamine, N-oleoyldopamine, ATP, lipoxygenase products
and monoacylglycerols4–6. TRPV1 behaves as a molecular
integrator of chemical and noxious heat stimuli in the
peripheral7 and central nervous system, determining nociceptive
responses8,9. For instance, TRPV1 behaves as thermosensory
transducer in central vasopressin neurons of the hypothalamus
and modulates dopaminergic mesolimbic system upon noxious/
stressor stimuli10.
With regards to its role in the central nervous system, it is widely
accepted that TRPV1 activation mostly modulates synaptic
transmission by a presynaptic mechanism11–14. Neurobehavioral
studies indicate that TRPV1 is critically involved in neurological
and psychiatric disorders such as epilepsy, anxiety and depression
as well as drug-addiction disorders15. Concerning TRPV1
expression, although still controversial16, much evidence indicates
that TRPV1 is expressed in neuronal and glial cells of various brain
regions, although at lower levels than in peripheral structures and
spinal cord17–20. The somatodendritic distribution of TRPV1 in
neurons did not always account for the presynaptic effect mediated
by this channel. However, compelling studies also indicate
postsynaptic TRPV1 activation as a trigger of some forms of
long-term synaptic depression21–24.
Some work on cultured microglia and microglial cell lines
shows that TRPV1 is also functionally expressed in brain resident
immune cells. Once activated, TRPV1 causes a variety of effects
ranging from microglia cell death to phagocytosis, cell migration,
cytokine production and ROS generation25–30.
In the present study, we investigated the roles of TRPV1 in the
anterior cingulate cortex (ACC) of the rodent brain31 and we
evaluated the impact of neuropathic pain on the channel
function. First, we found that TRPV1 is mainly functional
in the microglia rather than in neurons of both naı¨ve and
sham-operated mice. Its activation, beyond controlling microglia
reaction per se, modulated microglia-neuron communication,
by promoting release of extracellular vesicles (EVs) from
microglia. Indeed, EVs are important mediators of intercellular
communication between microglia and brain cells32, and sele-
ctively enhance neurotransmission by promoting sphingolipid
metabolism in excitatory neurons33.
Finally, we observed that in mice rendered neuropathic by
peripheral nerve ligation, TRPV1 is also expressed in cortical
neurons, and its activation directly affects both the intrinsic
membrane properties and the synaptic strength of cortical
pyramidal neurons (PNs), likely accounting for the increased
cortical excitability that characterizes chronic pain states.
Results
TRPV1 is expressed in microglia of ACC and other brain areas.
So far, immunohistochemical evidence (in which a variety
of polyclonal antibodies-pAbs-has been employed) showed
that in many brain areas TRPV1 is mostly present in neuronal
cell bodies, and rarely expressed in astrocytes and microglia
(Tables 1 and 2).
In the present study we found that a monoclonal anti-TRPV1
antibody (anti-TRPV1 MAb) stained fibers and cell bodies in
ACC sections of both adult (n¼ 9 mice; Fig. 1a,b) and young
mice (n¼ 8, Supplementary Fig. 1). The antibody specificity was
tested in tissue samples from TRPV1 / mice (n¼ 6 mice).
Unlike the anti-TRPV1 pAbs, neither cytoplasm nor fibers of cells
in tissues from TRPV1 / mice were marked by the
anti-TRPV1 MAb (Supplementary Fig. 2). Double immunofluor-
escence for TRPV1 and the neuronal marker NeuN showed
that the TRPV1 positive processes mainly surrounded neuronal
bodies (Fig. 1a, n¼ 4). Sparse overlapping between the two
antibodies was evidenced in confocal maximum projection
(Fig. 1a, NeuN/TRPV1 panel). However single 1–2 mm z-stacks
showed that merged signal did not result from neuronal staining
but could be attributed to the slight overlap of TRPV1
fibres surrounding neurons. The amount of colocalization
between TRPV1 and NeuN was ‘very weak’ as indicated by the
Pearson coefficient of correlation (PCC; r¼ 0.125±0.012,
n¼ 4; Fig. 1c)34. Subsequent double-immunostaining with the
anti-TRPV1 MAb and the microglial marker Iba1 revealed
that TRPV1 was mainly expressed in microglia (Fig. 1b), as
confirmed by the high degree of colocalization of TRPV1 and
Iba1 signals (r¼ 0.720±0.010, n¼ 5, Fig. 1c). These fluorescence
signals were higher in ACC sections of young than adult
mice (Supplementary Fig. 3). Thus, the largest part of TRPV1
was expressed in microglia although not all microglial cells
were TRPV1-embed (Supplementary Fig. 3).
To validate this hypothesis, analyses on highly purified neurons
and microglial cells from cortical wt and TRPV1 / tissues were
performed. Although mRNA transcript levels of TRPV1 were
comparable between neurons and microglia (Supplementary
Fig. 4a), protein analysis evaluated by flow cytometry revealed
low mean fluorescence intensity levels of surface TRPV1
expression in NeuN positive neurons (MFI¼ 48.2±7.4, n¼ 3
from 3 mice pools), whereas CD11b positive microglial cells
showed intense levels (MFI¼ 124.8±15.2, n¼ 3 from 3 mice
pools) (Fig. 1e,f). These findings were further corroborated
through western blot analysis on protein extracts of ACC and
postnatal cortical microglia cultures. TRPV1 was immunode-
tected as a band of 100 kD in the ACC extracts from wild type but
not from TRPV1 / mice (Supplementary Fig. 4b). We also
detected a second band of 75 kDa that was still revealed in
TRPV1 / tissues and was absent in cultured microglia cells
(non specific band, Supplementary Fig. 4b,c).
Consistent with a dominant microglial localization, we found
that, for equal total protein amounts, postnatal cortical microglia
cultures expressed higher level of TRPV1 compared with ACC
tissues (Supplementary Fig. 4d).
Finally, we performed patch-clamp recordings of GFP-expres-
sing microglial cells from acute Cx3cr1þ / ACC slices, to
directly detect the presence of functional TRPV1s in these cells.
A voltage ramp protocol was used to measure the current–voltage
relationship before and after the application of capsaicin. In these
conditions, we observed the activation of a capsaicin-evoked
outward rectifying current (Supplementary Fig. 4e), consistent
with the typical properties of TRPV1 channels1.
Altogether these data strongly indicate that functional TRPV1
is present in the microglia of mouse cortex.
The anti-TRPV1 MAb also labelled astrocytes of the
ACC (Supplementary Fig. 5a,c). Compared with microglia,
the TRPV1 expression was significantly lower in astroglial
cells (r¼ 0.084±0.006, n¼ 3, for anti-TRPV1/anti-GLAST and
r¼ 0.0753±0.004, n¼ 4, for anti-TRPV1/anti-GLT1; Po0.01 for
both markers; Two Sample t-Test). To test if the expression
level in astrocytes was dependent on the brain area, the hippo-
campus was chosen for comparison, to avoid a general under-
estimation of TRPV1 in astrocytes (Supplementary Fig. 5b,d).
A low degree of TRPV1-GLAST and TRPV1-GLT1 colocalization
was also detected in hippocampus (r¼ 0.176±0.019, n¼ 3;
r¼ 0.219±0.015, n¼ 4, respectively). These data indicated that
TRPV1 is expressed at much lower levels in astrocytes than in
microglial cells.
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The microglial TRPV1 expression pattern was also found
in other brain ‘painmatrix’ areas i.e thalamus, somatosensory
cortex, periaqueductal gray (PAG) and hippocampus
(Supplementary Fig. 6) while in the spinal cord and dorsal root
ganglia TRPV1 was detected also in neurons (as well established)
(Supplementary Figs 7–9), pointing to a selective microglial
expression of the receptor only in brain areas.
TRPV1s are expressed in cortical neurons of mice with pain.
Many studies demonstrated the fundamental role of TRPV1 in
pain induction and detection at peripheral structures and spinal
cord35, and compelling evidence indicates that TRPV1 is involved
in nociceptive processing also at brain level36–42. Our new
evidence on TRPV1 localization in brain microglia, prompted us
to assess the expression pattern of this channel in the ACC of
adult mice suffering from neuropathic pain at different time
points after the ligature of the sciatic nerve (chronic constriction
injury, CCI).
Three days after the nerve constriction, TRPV1 was expressed
in cortical microglia similarly to sham-operated mice (n¼ 3;
Supplementary Fig. 10). One week after CCI, anti-TRPV1 mAb
stained also the cytoplasm and the apical dendrite of Iba1
immunonegative cells whose morphology resembled neurons
(n¼ 5; Fig. 2a–h). This immunoreactivity pattern was limited to
layer 2/3 of both hemispheres and was less marked in the
ispilateral than in the contralateral hemisphere. At 4 weeks after
CCI, the cytoplasmic expression of TRPV1 in Iba1-negative cells
was broadly distributed throughout all layers of the contralateral
hemisphere (Fig. 2i–p; n¼ 7). In line with these observations,
TRPV1 microglial expression decreased in the contralateral
ACC of 1 week and 4 week CCI mice. Indeed, the Pearson
correlation coefficient for anti-TRPV1/Iba1 signal colocalization
was weaker in the contralateral ACC of 1 week and 4 week CCI
mice compared with ispilateral cortices (Fig. 2q–t). Double
immunofluorescence staining with NeuN and anti-TRPV1
revealed that TRPV1 was expressed in both cytoplasm and
branches of NeuN-positive neurons (n¼ 3; Fig. 3a), thus
suggesting that in CCI adult mice TRPV1 was expressed in
cortical neurons, besides microglial cells. Triple immunofluores-
cence labelling for NeuN, TRPV1 and EAAC1 (the neuronal
glutamate transporter marker) showed that vanilloid receptor
type 1 was mostly expressed in pyramidal neurons. Indeed,
whereas almost all EAAC1 immunopositive neurons expressed
TRPV1 (Fig. 3b), only a small fraction of EAAC1 negative
neurons were immunoreactive for TRPV1 (n¼ 3).
The neuronal expression pattern was prominent in ACC,
although other areas of the painmatrix such as the thalamus,
somatosensory cortex, PAG and hippocampus displayed sporadic
TRPV1 neuronal expression. The anti-TRPV1 MAb labelling of
neurons was absent in cortical sections from CCI TRPV1 /
(Supplementary Fig. 11).
In cortical sections from young CCI mice, TRPV1 was never
detected in neurons, at none of the time points tested (3,7 and
14 days post-CCI; Supplementary Fig. 1b,c).
Microglial TRPV1s control glutamatergic neurotransmission.
Growing evidence shows that activation of brain microglia
modulates excitatory neurotransmission and increases synaptic
Table 1 | TRPV1 antibodies employed in brain studies.
Species N-terminal C-terminal Staining pattern TRPV1 / Company Authors
Rabbit Polyclonal þ  Cell bodies (nucleus and
cytoplasm), dendrites,
and terminals
 Immunological Sciences Marinelli et al.70
Rat polyclonal  þ Neuronal cytoplasm and
microglial branches
 Sensory Research Center
Seoul National University
(Seoul, Korea)
Kim et al.25
Rabbit Polyclonal  þ Neuronal cell bodies and
dendrites
 Chemicon (Temecula, CA,
USA)
To`th et al.18
Rabbit Polyclonal  þ  Calbiochem (San Diego,
CA., USA)
Guinea pig  þ Neuronal cytoplasm þ Dr Julius Lab, UCSF Cavanaugh et al.16
Guinea pig  þ Neuronal cytoplasm  Harlan (Indianapolis, USA) Mezey et al.17
Rabbit þ   New Zealand White
Goat Polyclonal þ  Neuronal cytoplasm and
processes
þ


Santa Cruz Biotechnology,
(Santa Cruz, CA, USA)
Cristino et al.19; Maione et al.71;
Fogac¸a et al.72; Casarotto
et al.73;
Rabbit Polyclonal þ  microglial processes and
cell bodies
 Novus Biologicals (Littleton,
CO)
Sappington and Calkins26
Guinea pig
Polyclonal
 þ Neuronal cytoplasm  Abcam (Cambrige, UK) Maione et al.74
Table 2 | TRPV1 antibodies employed in the present study.
Species N-terminal C-terminal Staining pattern TRPV1 / Company
Rabbit Polyclonal  þ Neuronal cytoplasm þ Neuromics
Rabbit Polyclonal þ  Neuronal cytoplasm þ Immunological Science
Mouse Monoclonal  þ Microglial branches and neuronal cytoplasm þ Millipore Bioscience Research
Note that ‘þ ’ in the TRPV1 / columns indicates that the antibody has been tested in tissue from TRPV1 / mice.
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strength43–45. Given our data on TRPV1 expression in brain
microglia, we hypothesized that the well-characterized
presynaptic modulation of neurotransmission by TRPV1 may
be indirect, due to stimulation of TRPV1 on microglia rather than
on neurons.
To address this possibility, we first explored the action
of TRPV1 stimulation in the ACC. As reported for other brain
areas, capsaicin (1 mM) selectively increased the frequency of
miniature excitatory postsynaptic currents (mEPSCs) onto PNs of
ACC without affecting their amplitude (Fig. 4a). This effect is due
to a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
receptors activation (AMPA; Supplementary Fig. 12).
Both genetic deletion and pharmacological blockade of TRPV1
by the non-competitive antagonist IRTX inhibited the enhance-
ment of mEPSC frequency by capsaicin (Fig. 4b).
Among the signalling lipids that are able to activate TRPV1,
we tested the lysophosphatidic acid (LPA). This bioactive
and proinflammatory lysophospholipid is highly produced
during inflammation and activates microglial cells which,
in turn, self-sustains LPA synthesis46,47. Beyond acting on its
high-affinity metabotropic receptors LPA1–4, LPA also binds
to the TRPV1 C-terminal48. Similarly to capsaicin, LPA
significantly enhanced the frequency of mEPSCs (Fig. 4c) and
did not affect mEPSC amplitude (Po0.9). The enhancement of
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Figure 1 | TRPV1 protein expression in microglial and neuronal cells of the ACC of adult naive mice. (a) Photomicrograph of double
immunofluorescence for anti-TRPV1 MAb (green) and NeuN (magenta). The anti-TRPV1 MAb labels mainly fibers that surround neurons (NeuN positive
cells) and sparse NeuN negative cytoplasm (arrows). (b) Anti-TRPV1 positive processes highly overlap with the microglial marker iba1 (in red) in the layer
2/3 of ACC. (a,b) DAPI, nuclear marker (in blue). (c,d) Graphic representation (scatter plot) of the correlation coefficient of Pearson (PCC) for quantifying
the colocalization between the anti-TRPV1 and NeuN (in yellow, PCC¼0.13) and anti-TRPV1 and Iba-1 (PCC¼0.77). Note that higher PCC values
correspond to a strong colocalization32. (e,f) Neuronal and microglial cells were isolated from cortical tissue using specific magnetically labelled kits.
According to physical parameters, obtained cells were gated on NeuN and CD11b for identification of neurons (e) and microglial cells (f) respectively.
Surface expression of TRPV1 was analysed by means of flow cytometry. Data are representative of a single experiment and show the mean fluorescence
intensity (MFI) of 3 independent pools of at least 3 mice.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15292
4 NATURE COMMUNICATIONS | 8:15292 | DOI: 10.1038/ncomms15292 | www.nature.com/naturecommunications
mEPSC rate by LPA was significantly dampened in slices
incubated with IRTX (Fig. 4e) and was completely abolished
when both TRPV1 and LPA metabotropic receptors were
blocked (Fig. 4g). Taken together, these data suggest that
LPA may behave as a potential endogenous activator of TRPV1
in the brain.
Then, we performed a set of experiments in the presence of the
tetracycline minocycline. This antibiotic exerts anti-inflammatory
and antimicrobial effects by preventing microglia activation49,50.
Minocycline (100 nM) did not affect basal mEPSCs (from
2.34±0.59 to 2.28±0.66Hz, P¼ 0.85 and from 19.54±1.49 to
19.29±1.62 pA, P¼ 0.82; n¼ 9) but fully inhibited the capsaicin-
induced increase of mEPSC rate (Fig. 5a–c). These data strongly
suggest that the enhancement of glutamatergic neurotransmission
by capsaicin is due to the activation of TRPV1 expressed by
microglia cells.
To assess whether astrocytes work as mediators of
microglia-neuron communication upon TRPV1 activation,
capsaicin was tested in the presence of the glial-specific
toxin fluoroacetate (FAc)43,51. We found that capsaicin
still enhanced mEPSCs rate (Fig. 5d,e,f), thus suggesting that,
at least in these experimental conditions, astrocytes are not
required for this type of TRPV1-mediated microglia-to-neuron
communication.
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TRPV1 activation stimulates microglial microvesicle release.
Next step was to define the molecular mechanism underlying
the increase of mEPSC frequency driven by microglial TRPV1
activation. Among several factors, microglia-to-neuron commu-
nication occurs through EVs shed from the plasma membrane of
microglia, called microvesicles (MVs) or ectosomes33,52.
Production of MVs increases in reactive microglia53, and is
strongly enhanced by ATP through activation of P2X7
receptors54. Hence, TRPV1 stimulation on microglia may
promote MV shedding as well. To verify this hypothesis,
cultured murine microglia were challenged with capsaicin
(300 nM) for 10min and EVs, both shed MVs and smaller
vesicles, were quantified and sized by nanoparticle tracking
analysis (NTA). NTA showed a multimodal size distribution of
quite large vesicles, presumably MVs (mean diameter
control¼ 298.2±21.2 nm; capsaicin¼ 305.0±16.32 nm; n¼ 3),
with a major peak consisting of vesicles about 200 nm in size and
few smaller peaks of larger MVs (Fig. 5g). EV concentration
increased by 1.5 fold under TRPV1 or ATP stimulation (Fig. 5h,
n¼ 3). Selective quantification of MVs shed from microglia that
have incorporated fluorescent phosphocholine (NBD-C6_HPC)
in the plasma membrane, confirmed that both ATP and capsaicin
enhance MV production to the same extent (Fig. 5i, n¼ 3;
Po0.05).
These data suggest that capsaicin may increase mEPSC rate by
triggering release of MVs upon TRPV1 activation on microglia.
To this aim, we employed an inhibitor of acid ceramidase, the
ARN14988 (ref. 55), to prevent neuronal sphingosine production,
essential for MV-induced stimulation of synaptic activity33. This
compound did not affect, per se, basal mEPSC frequency,
although it slightly reduced their amplitude (Supplementary
Fig. 13a). In slices pre-treated with ARN14988, capsaicin did not
affect either frequency or amplitude of mEPSCs (Fig. 5j). To
exclude possible inhibitory effects of ARN14988 on MV
production or activity, microglia cultures were treated with the
ceramidase inhibitor before exposure to capsaicin. NTA
quantification showed that ARN14988 did not inhibit
capsaicin-dependent MV release (Supplementary Fig. 13b).
Furthermore, patch-clamp recordings revealed that MVs from
ARN14988-treated cells retained the capability to increase
mEPSC frequency in cultured neurons (Supplementary Fig. 13c).
To strengthen our hypothesis, we pharmacologically blocked
MV shedding from microglia with the p38 MAPK inhibitor
SB203580. p38 MAPK activates downstream P2X7 ATP receptor
and is essential for MV shedding56. Given that p38 MAPK is
activated downstream TRPV1 receptors57, we reasoned that
inhibition of p38 MAPK could block capsaicin-induced MV
shedding as well. Indeed, capsaicin-induced MV shedding from
cultured microglia treated with SB-203580 was significantly
reduced (Supplementary Fig. 13d). Finally, capsaicin failed to
affect the frequency and amplitude of mEPSCs in slices incubated
with SB-203580 (Fig. 5k).
Altogether, these data suggest that capsaicin possibly increases
spontaneous glutamatergic synaptic activity by promoting
shedding of microglial MVs, which in turn fosters sphingosine
metabolism in neurons and enhances presynaptic release
probability.
TRPV1 controls cortical microglia activation. In the healthy
mature brain, microglial cells play a role in immune surveillance
and ensure the maintenance of brain homeostasis. Upon injuries
these cells shift to an activated state characterized by drastic
changes in the cellular shape, functional behavior and by the
release of different proinflammatory and immunoregulatory
factors58,59. Conforming to the capsaicin-mediated induction of
microglial chemotaxis29, we investigated whether TRPV1
stimulation regulates the morphology of microglial cells.
Morphometric analyses (ImageJ plugin, Supplementary
Fig. 14a) showed that the majority of microglial cells from acute
slices incubated in ACSF had a ramified shape, displaying small
cell bodies with thin and elongated processes (Fig. 6a,g).
Compared with controls (vehicle and ACSF treated slices)
(Fig. 6a,b), sections incubated with 1mM capsaicin for 10min
displayed a bulk of hypertrophied iba1 positive cells showing
larger cell bodies, and thicker, shorter and highly branched
projections (Fig. 6c,g). Of note, capsaicin-induced morphological
changes were absent in sections from TRPV1 / mice
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(Fig. 6f,h). In the latter, microglia displayed already a hyper-
trophied morphology under baseline conditions. (Fig. 6d–f,h;
Supplementary Fig. 14b). Subsequent flow cytometry experiments
revealed that WT microglia challenged with capsaicin produced
significantly higher levels of TNF-a and lower levels of IL-10
(Fig. 6i,j), whereas TRPV1 / microglia expressed equal
amounts of TNF-a with compared with WT cells and
significantly greater amounts of IL-10 (Fig. 6i,j). Thus, stimula-
tion of TRPV1 induced a pro-inflammatory phenotype of
microglia from WTs. Conversely, microglia shifted toward an
anti-inflammatory phenotype when TRPV1 is lacking.
We next asked whether TRPV1 might be endogenously active
under inflammatory conditions. Lipopolysaccharide (LPS), the
most abundant component within the cell wall of Gram-negative
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bacteria, exerts inflammatory action by activation of microglia.
500 ngml 1 LPS increased the mEPSC frequency without
affecting their amplitude (35% of mEPSC frequency enhance-
ment, Fig. 7a,b)43. This effect was tightly restricted to activation
of glial cells, since it was consistently blocked by minocycline
and by the astroglia blocker FAc (1mM) (from 5.73±1.13
to 5.80±1.24Hz, n¼ 11, P¼ 0.49; from 18.52±1.48 to
18.01±1.40 pA, n¼ 11, P¼ 0.22).
The overall increase of glutamatergic neurotransmission by
LPS was significantly reduced by IRTX (n¼ 14, Po0.05; Fig. 7c
right panel). Likewise, both the enhancement of mEPSCs
and morphological changes induced by LPS were absent in
TRPV1 / mice (Fig. 7d and Supplementary Fig. 14c,
respectively).
Along with these data, application of capsaicin following
saturating LPS failed inducing any further potentiation of
mEPSCs onto PNs (Fig. 7e,f). These results suggest that the
lack and/or block of TRPV1s prevent the inflammatory effects of
LPS by keeping microglia in an M2 anti-inflammatory state.
TRPV1s affect neuron excitability and synaptic strength.
TRPV1 expression in the soma and dendrites of cortical
pyramidal neurons (PNs) of CCI mice may directly affect
neuronal excitability, thereby enhancing cortical hyperexcitability,
a distinct feature of chronic pain.
In baseline conditions, neither input resistance
(shams 137.37±9.9MO n¼ 24, CCI 147.12±10.6MO n¼ 23,
P¼ 0.5, Two Samples t-Test) nor resting membrane potential
(shams  70.96±1.52mV n¼ 24, CCI  67.93±2.65mV
n¼ 23,P¼ 0.32, Two Samples t-Test) of PNs neurons from sham
and CCI mice were different. However, the number of action
potentials evoked by current injections of increasing amplitude
was significantly higher in CCI than in shams (Supplementary
Fig. 15a left and right input-output curves, respectively). The
increase of firing can be ascribed, at least partly, to TRPV1
expression in CCI mice neurons, since IRTX caused a rightward
shift in the input current-action potential rate curves
(Supplementary Fig. 15b). In parallel, mEPSC frequency was
enhanced in CCI mice compared with control animals (Supple-
mentary Fig. 15c). Unexpectedly, the amplitude of mEPSCs was
greatly reduced (Supplementary Fig. 15d). The amplitude drop of
spontaneous glutamatergic currents could be attributed to AMPA
receptor trafficking, as a neuronal homeostatic mechanism
subsequent to the persistent increase of synaptic activity60.
Application of capsaicin, besides frequency (as in control mice,
see Fig. 4) significantly scaled up both amplitude and charge
transfer of mEPSCs in 10 out of 18 PNs recorded from CCI mice
(12% and 16% increase, respectively; Fig. 8a–c). To dissect
out microglial versus neuronal TRPV1 contribution in the
capsaicin-induced increase of synaptic strength, PNs from CCI
mice were recorded in the presence of minocycline. In a similar
proportion of neurons recorded in these conditions (4 out of
13 neurons, P¼ 0.39 w2-test), capsaicin significantly enhanced the
mEPSC amplitude and the charge transfer, indicating that only
neuronal TRPV1s account for capsaicin effect on miniature
synaptic events (Supplementary Fig. 15e).
Beside its effects on the glutamatergic transmission, capsaicin
(1 mM) induced a slight but consistent membrane depolarization
associated with a significant reduction of the input resistance in
PNs of CCI mice (Fig. 8d,e). This effect was independent from
postsynaptic glutamatergic or GABAergic ionotropic receptors
stimulation, as it was obtained in the presence of DNQX, APV
and picrotoxin. Conversely, in neurons from shams (Fig. 8e) we
found no change in the same intrinsic membrane parameters. In
voltage-clamp experiments, capsaicin elicited inward currents
associated with a significant enhancement of membrane
conductance in CCI PNs, but not in shams (Fig. 8f,g). In
capsaicin-responding neurons (n¼ 4), IRTX successfully reverted
capsaicin-induced inward current (Supplementary Fig. 15f–g).
Discussion
The present study shows that TRPV1 is expressed and functional
in the microglia of the anterior cingulate cortex of healthy mice.
Notably, TRPV1 activation directly affects microglia function,
which in turn modulates synaptic neurotransmission. This
evidence arises from: (a) mRNA TRPV1 expression in cortical
microglia, validated by the lack of expression in cells from knock
out tissue as negative control; (b) high levels of TRPV1 protein
expression in cortical microglia cells as indicated by western
blotting, flow cytometry and immunofluorescence assays in
cortical tissue; (c) the outward rectifying current induced by
capsaicin in microglia cells from cortical slices; (d) the shedding
of microvesicles from microglial surface upon capsaicin applica-
tion; and (e) morphological and phenotypic changes of microglial
cells upon TRPV1 activation. Importantly, TRPV1-mediated
increase of cortical spontaneous glutamatergic neurotransmission
is absent when microglia is switched off by minocycline and is
occluded by the inflammatory agent LPS. Conversely, we found
that in the cortex of mice suffering from neuropathic pain,
TRPV1 is expressed also in neurons, affecting their intrinsic
electrical properties and synaptic strength. This different TRPV1
expression pattern under chronic pain conditions places
Figure 5 | TRPV1 is functionally expressed in cortical microglia and modulates synaptic transmission by microvesicles shedding. (a) Example recording
of mEPSCs before (left) and during (right) capsaicin in the presence of minocycline. (b) Cumulative probability plots comparing minocycline (black line)
and minocycline plus capsaicin (red line) on mEPSC IEI and amplitude of the recording showed above (P¼0.25 and P¼0.31, KS test). (c) Bar histograms of
group data showing the lack of capsaicin-mediated increase of mEPSC rate when microglia activation is blocked by minocycline (from 3.98±0.35 to
4.13±0.33Hz, n¼9, P¼0.53; from 17.54±0.94 to 17.34±0.79 pA, n¼9, P¼0.70, Paired Sample t-Test). Group data are presented as single value and
mean±s.e.m. (d) Example recording of mEPSCs before (left) and during (right) capsaicin in the presence of 1mM FAc. (e) Cumulative probability plots
comparing FAc (black line) and minocycline plus capsaicin (red line) on mEPSC IEI and amplitude of the recording showed above (Po0.01 and P¼0.28,
KS test). (f) Summary data of both mEPSC frequency and amplitude recorded in the presence of FAc before and during capsaicin application
(FAc 5.30±0.72Hz, FAcþ caps 6.70±1.10Hz, *Po0.05 Paired t-test; FAc 18.58±1.55 pA, FAcþ caps 18.63±1.98 pA, n¼ 7, P¼0.89 Paired Sample
t-Test). (g) Representative size profile of EVs released constitutively (black line) or upon capsaicin challenge (red line) from 5 105 murine microglia in
500ml of serum free medium during a period of 10min. (h) Histogram showing the fold increase of total EV concentration detected by Nanosight upon
stimulation with ATP or capsaicin (Kruskal-Wallis test, P¼0,035). (i) Histogram showing the fold increase of MVs shed selectively from the plasma
membrane and measured by a spectrophotometric assay under the same stimuli (Holm-Sidak’s, Po0,05). (j) Group data showing that addition of
ARN14988 reduces capsaicin-mediated increase of mEPSC frequency in cortical slices (from 11.51±0.92 to 12.12±0.88Hz, P¼0.15; from 14.52±0.61 to
14.10±0.46 pA, P¼0.06, Paired Sample t-Test, n¼ 10). (k) Summary graph of mEPSC frequency (left) and amplitude (right) in the presence of 2 mM
SB203580 before (black bar) and after capsaicin (blue bar) (from 9.30±1.00 to 9.93±0.90Hz, P¼0.08; from 10.67±0.47 to 10.75±0.49 pA, n¼ 11,
and P¼0.89, Paired Sample t-Test and Wilcoxon Signed Rank Test, respectively). Data are values from single cells and/or mean±s.e.m. *Po0.05.
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Figure 6 | The presence or absence of TRPV1 influences microglia phenotype. (a–f) Sections of cortical tissue fromWTand TRPV1 / mice, fixed after
exposure to ACSF (a,d), ACSF plus vehicle (DMSO; b,e) and ACSF plus 1mM capsaicin (c,f) and immune-processed for iba-1 to stain microglia cells (in red).
INSETs are zoom images taken from an area delimited by the yellow square for each condition. (g), Bar graph of percentage of cortical microglia cell
phenotype (resting, ameboid, bushy and hypertrophied), in control (grey bars), vehicle- (dark grey bars) and capsaicin- treated (red bars) cortical sections
from WTmice. Capsaicin treatment causes a significant shift from ramified and bushy to hypertrophied morphology. (h), Same as in ‘g’ but in cortical
sections from TRPV1 / mice. In these tissues capsaicin fails to induce morphological changes of microglia cells. Note that microglia cells in  /
tissues are already hypertrophied in control conditions (d–f,h). *Po0.05, **Po0.01 Fisher exact test. Acutely isolated CD11bþ microglial cells from WT
(i) and TRPV1 / mice (j) were cultured in the absence ( ) or presence (þ ) of capsaicin (1 mM) for 10min, washed and then incubated with Brefeldin A
for 6 h to allow cytokine accumulation in vesicles. Intracellular production of TNF-a and IL-10 was analysed by means of flow cytometry. Data represent
percentage of cytokine production±s.e.m. of 3 independent pools of at least 3 mice. *Po0.05, **Po0.01 (Bonferroni’s multiple comparison test following
parametric one-way Anova). Note that ‘Percentage of TNFalpha/IL-10 production’ means the ‘Percentage of TNFalpha producing cells’.
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Figure 7 | TRPV1 tonically controls LPS-mediated effects. (a) Example recording of mEPSCs in control (ctrl) and during LPS exposure (500ngml 1).
Below the cumulative probability plot of mEPSC interevent interval and amplitude (Po0.01 and P¼0.24, respectively, KS test). (b) Population plot of
mEPSC frequency before (black bar and filled circle) and during LPS (violet bar and filled circle), showing that LPS, similarly to capsaicin, increases
selectively the mEPSC frequency (from 7.67±1.32 to 10.09±1.73Hz, n¼ 14, Po0.001 Paired Sample Wilcoxon Signed Rank test) without a significant
effect on the amplitude (from 20.05±1.30 to 19.76±1.32 pA, P¼0.5 Paired Sample t-Test). (c) As in b, but in the presence of 300 nM IRTX
(from 6.8±1.06 to 7.78±1.19Hz, n¼ 14, Po0.01 Paired Sample Wilcoxon Signed Rank test; from 17.47±1.17 to 17.11±1.23 pA, P¼0.09 Paired Sample
Wilcoxon Signed Rank test). Right, the percentage increase of mEPSC frequency by LPS in the presence of the TRPV1 antagonist IRTX, is significantly
reduced compared with the rate enhancement induced by LPS applied alone (P¼0.01 Mann–Whitney test). (d) Population data of mEPSC frequency in
control and during LPS obtained from PNs of TRPV1 / mice (from 7.36±1.90 to 7.69±1.81Hz, n¼ 9, P¼0.52 Two Samples t-Test). (e) Trace records
from a PN in control condition (ctrl), in LPS and LPS plus capsaicin. Following LPS perfusion, capsaicin is no longer able to further facilitate glutamatergic
neurotransmission. Right below, cumulative distribution probability of the interevent intervals from the same neuron (ctrl versus LPS P40.0001, LPS versus
caps Po0.0001, ctrl versus caps P¼0.54). (f) Summary graph of mEPSC frequency before (black bar), during LPS (violet bar) and LPSþ caps (red bar)
(ctrl 6.69±1.15 LPS 8.78±1.68Hz, LPSþ caps 8.45±1.97Hz, n¼ 7,ctrl versus LPSPo0.05, LPS versus LPSþ caps P¼0.68, ctrl versus LPSþ caps
P¼0.15 Paired Sample t-Test;. Data are values from single cells and/or mean±s.e.m. *Po0.05, **Po0.001.
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microglial TRPV1 at the center of a new important mechanism,
providing a link between physiological and pathological states.
TRPV1 is functional in in vitro microglia26–29 and growing
evidence indicates a modulatory role of excitatory neurotrans-
mission by microglia cells43–45. Accordingly, our study
demonstrates that, in resting conditions, acute activation of
TRPV1 expressed in microglia accounts for the well-known
presynaptic modulation of glutamatergic neurotransmission by
this channel observed in several rodent brain areas, and adds new
insights on the apparent paradox of a postsynaptic TRPV1
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Figure 8 | Neuronal TRPV1 stimulation directly modulates layer 2/3 pyramidal neuron synaptic strength in CCI mice. (a) Example recording of mEPSCs
before and during capsaicin from a CCI pyramidal neuron. Note that capsaicin increases both the frequency and amplitude of mEPSCs. (b) Cumulative
probability plots comparing the IEI (left panel), amplitude (middle panel) and area (right panel) of control mEPSCs with those recorded in capsaicin,
(KS-test Po0.001). (c) Summary graph of mEPSC frequency (left), amplitude (middle) and peak area (right) before (black bar, solid circle) and during
capsaicin (red bar, solid circles) (frequency from 6.73±1.05 to 7.66±1.02Hz, P¼0.05 Paired Sample t-Test; amplitude from 12.90±0.84 to 14.26±0.95
pA, Po0.01 Paired Sample Wilcoxon Signed Rank test; Area from 52.03±2.67 to 60.20±3.74 pA*ms, Po0.05 Paired Sample t- test; n¼ 10).
(d) Left, current-clamp recording of a pyramidal neuron responding to capsaicin with depolarization and reduced RM. Negative deflections are membrane
potential responses to negative current injections (60pA). Right, plot of %DRM (normalized to pre- capsaicin values) versus DVM (membrane potential
values in capsaicin subtracted from baseline ones) in all tested neurons from CCI and sham mice (n¼ 18 and n¼ 12, filled and white symbols, respectively).
These data were analysed by performing a linear fit to evaluate the strength of association between the two variables, through the coefficient of
determination r2. In sham, DRM values do not correlate with variations in DVM (r2¼0.07) while in PNs from CCI mice, capsaicin-induced changes of
VM correlate with a RM with a value of r
2¼0.36. (e), Summary time plot of subtracted membrane potential (DVM) of CCI and sham PNs in response to
capsaicin (Po0.001, Two Sample t-Test). (f) Left, example of voltage-clamp recording (at  70mV) of a CCI PN responding to capsaicin with an inward
shift of the holding current. Vertical deflections (truncated in the figure) are membrane current responses to voltage steps to test passive properties and
recording stability. Right, population graph of membrane conductance in control (black bar) and during capsaicin perfusion (red bar; n¼ 12; *Po0.05 Paired
Sample Wilcoxon Signed Rank test). (g), Summary plot of DIM (membrane current values during capsaicin subtracted to baseline values) versus time for
PNs from sham and CCI mice (n¼ 12 and n¼ 14, respectively; Po0.001, Mann–Whitney test).
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localization inducing presynaptic effect on glutamate release15,61.
In addition to the glutamatergic hypothesis, microglia affects
neuronal excitability also by disinhibition mechanisms62, thus
likely explaining the TRPV1 regulation of inhibitory
neurotransmission at dentate gyrus synapses63. Differently, in
‘activated’ conditions, our evidence on TRPV1 functional
expression in neurons may argue for the postsynaptic TRPV1
modulation of some forms of long term depression21–24.
The different expression pattern revealed by the anti-TRPV1
MAb and the polyclonal antisera lies in the well-known
uniqueness of antibodies whose ability to recognize the
epitope relies heavily on the experimental technique employed
(in which proteins can be variously fixed or unfixed, denatured or
undenatured). Indeed, the anti-TRPV1 MAb also recognized the
native neuronal receptor in the cytofluorimetry assay on living
neurons. This demonstration of TRPV1 cortical microglia
expression is complemented by the evidence at the mRNA level,
exploiting probes covering the exon sequence lacking in the
TRPV1 mutant mice: TRPV1 mRNA is copiously expressed in
purified cortical microglial cells, as well as in neurons, while no
significant amount is detected in TRPV1 / tissue and cells.
Hence, our data do not exclude the existence of a functional
TRPV1 postsynaptically expressed, but posit that this channel in
neurons could be activated upon specific stimuli, thus not
showing up under our experimental conditions of the immuno-
fluorescence and electrophysiological analysis. Indeed, only
models of long term synaptic plasticity unveil a TRPV1-mediated
postsynaptic effect21–24.
In contrast to our and other studies17–20, evidence using
TRPV1 reporter transgenic mice, led to the conclusion that
TRPV1 expression is low and restricted to few brain areas16.
Different reasons could underlie this discrepancy. First, the
protein expression levels downstream of IRES sequences are
variable, and can be lower than that from the cap-dependent
translation of the primary mRNA64,65. This might lead to
artificially low reporter levels in brain areas that do express
TRPV1. Second, the putative reporter mRNA is very long,
encompassing TRPV1, PLAP and lacZ coding sequences, which
may well have a different stability and shorter half-life. Third, the
precise genomic context around a reporter gene can significantly
affect the chromatin organization of that locus and thus the
expression pattern of the reporter gene. Thus, a systematic
comparative study revealed significant differences between Cre
recombination patterns and the expression pattern of the
endogenous genes. In conclusion, the expression pattern of the
reporter genes in a transgenic mouse might not always precisely
mimic the real expression of the endogenous gene. Intriguingly,
since the identity of the TRPV1-positive cells stained in the brain
by the lacZ reporter was not investigated16, these cells could also
include the glial cells immunopositive for the TRPV1 monoclonal
antibody identified in the present study.
Remarkably, the present data clarify the TRPV1 role in the
brain with respect to that held by the same receptors in the
peripheral somatosensory system. Indeed, TRPV1s expressed in
the main immune cells of the brain may similarly function as
detectors of nociceptive and inflammatory stimuli/agents.
Accordingly, we found that capsaicin shifted microglia to a
hypertrophic and pro-inflammatory state by increasing the
production and release of cytokines that is, TNFa. Other studies
showed increase production of L6 and ROS formation following
TRPV1 activation in microglial cells26,27.
Notably, during inflammation or upon more generic environ-
mental cellular insults, potential endovanilloids such as
n-acyl amides, monoacylglycerols and bioactive lipids markedly
increase46,66,67. Among these candidates, LPA seems to be
a suitable endogenous agonist since, similarly to capsaicin, it
activates potassium outward currents in microglia cells and
induces microglial microvesicles shedding68,69. Our present data
unveil a TRPV1-mediated enhancement of excitatory neuro-
transmission by LPA. Certainly, other candidates cannot be
excluded i.e. the N-acylethanolamides anandamide, palmitoyl-
ethanolamide, oleoylethanolamide and monoacylglycerols6.
Remarkably, we found that when TRPV1s are defective,
microglia shift to anti-inflammatory phenotype, by producing
large amounts of IL10. Given the substantially reduced effects of the
endotoxin LPS in TRPV1 / slices, we hypothesize that loss-of-
function mutations of TRPV1 may keep these cells in a refractory
status and decrease the immunological response to pathogens.
The morphology of microglial cells activated by capsaicin is in
line with the observed enhancement of excitatory neurotransmis-
sion by microglial TRPV1 stimulation. Previous findings under-
scored how the amount of contact/interactions between microglia
processes and neuronal compartments shapes neuronal
excitability. In particular, the fewer microglial processes contact
neurons (activated microglia), the greater is the synaptic neuronal
activity and the surface expression of AMPA receptors.
Similarly to other proinflammatory agents53, we found that
capsaicin promotes the shedding of microglial MVs, suggesting
that endovanilloid signalling may represent another route for
a rapid propagation of inflammatory signals from microglia to
neurons. The potential involvement of MVs in TRPV1-mediated
microglia-to-neuron communication is indicated by a significant
reduction of capsaicin-induced increase of mEPSC frequency
under inhibition of p38 MAPK phosphorylation and block of
sphingosine metabolism. While the first is essential for MV
shedding, since its activation causes the translocation into the
plasma membrane of a key enzyme (acid sphingomyelinase)
mediating MV budding56, the latter is a crucial step for the fusion
of synaptic vesicles with the neuronal plasma membrane and,
therefore, is a key effector of presynaptic stimulation of excitatory
transmission mediated by MVs33.
Recent evidence points to astrocytes as a relay between
microglia to neuron communication43. However this would not
be the case of our study because, despite the block of astroglia,
acute stimulation of TRPV1 still affects neurotransmission.
An additional potential mechanism underlying TRPV1-
mediated microglia-to-neuron communication could be the
release of microglial factors from MV breakage or from microglia
cells themselves, which modulate glutamatergic neurotransmis-
sion via the interaction with their downstream receptors
(Supplementary Fig. 17). Further experimental work is needed
to address this possibility.
A major finding of this study is the expression of TRPV1
also in neurons of adult mice suffering from neuropathic pain.
This new TRPV1 cellular distribution might be part of
a homeostatic response that links physiology to pathology and
is time-dependent from pain onset, being absent at early stages
and gradually overspreading in all cortical layers of the
contralateral hemisphere once the chronicization endures. Since
our data indicate that under control healthy mice conditions
TRPV1 mRNA is present in cortical neurons, we assume that
a post-transcriptional regulation mechanism of gene expression
may account for the new functional expression of TRPV1 protein
in the cortex of mice affected by neuropathic pain, that is, an
increase of translational efficiency or a decrease of protein
degradation in neurons, activated by the persistent central
sensitization in chronic pain conditions. The possibility of
translational control of TRPV1 mRNA would call naturally into
play TRPV1-selective miRNAs in neurons, that might release
their translational repression in an activity dependent manner,
under the chronic pain conditions that we demonstrated to
induce ACC neuronal expression of TRPV1.
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Similarly, changes of TRPV1 cellular expression were shown in
DRG neurons during inflammation, reasoning for a different role
of this protein at different stages of hyperalgesia.
Importantly, we never found anti-TRPV1 positive neurons
in the cortex, thalamus and hippocampus of young mice
(two/three weeks old), at different time points from neuropathic
pain onset. Given that neuropathic pain is constitutively
suppressed during early life by anti-inflammatory neuroimmune
regulation, the shift of TRPV1 expression in cortical neurons of
adult mice may be linked to glial released inflammatory factors
during the central sensitization in neuropathic pain. Once
released at the site of injury, cytokines, growth factors and
prostaglandins, in addition to contributing to peripheral and
central sensitization mechanisms, are capable of signaling to the
brain via both neural and blood-borne routes and, once within
the brain, they result in de novo production by glial cells.
Based on the above observations, we hypothesize that
inflammatory molecules may regulate post-transcriptional
mechanisms of gene expression by enhancing neuronal TRPV1
protein translation, possibly via activity-dependent miRNA-
mediated mechanisms.
At least in our mice with neuropathic pain, neuronal TRPV1
expression is consistently restricted to the ACC, rather than other
brain areas in which the neuronal distribution of this receptor is
only occasionally observed. To note, cortico-spinally projecting
neurons play direct effect on pain regulation, undergoing synaptic
pontentiation following nerve injured. Probably these cortically
spinally projected neurons may be our TRPV1 immunopositive
neurons in mice whose nerve was injured. In fact, TRPV1
activation modulates both intrinsic and extrinsic excitability
of these cells by increasing their firing rate, depolarizing
membrane potential and enhancing synaptic strength. Together,
these data suggest that TRPV1 in cortical PNs of neuropathic
mice may be crucial for the enhanced cortical activity and
alteration of the emotional component in subjects affected by
chronic pain. Actually, TRPV1 mediates both anxiety and
emotional alterations.
The contribution of microglial TRPV1 to the hyperexcitability
and synaptic strength of CCI PNs appears to be, on the other hand,
less relevant, as shown by the persistence of these features when
microglia function is blocked. This conclusion is supported by the
reduced TRPV1 expression in cortical microglia of CCI mice as
well as by the well-standardized presynaptic effect of MVs.
Hence, neuronal TRPV1 maybe the effective player in changing
the electrophysiological properties of PNs, once pain becomes
chronic.
On a final note, our study suggests that future strategies aimed
at imaging TRPV1 cellular expression and distribution may
provide differential diagnostic tools for pathologies associated
with an inflammatory brain component.
Methods
All experiments were performed in accordance with Directive 2010/63/EU of the
European Parliament and of the Council on the protection of animals used for
scientific purposes, and approved by both the animal-welfare body (article. 25 of
Legislative Decree 26/2014), established at the registered facility ‘Fondazione Santa
Lucia’ and the Italian authority veterinary service (Italian Ministry of Health). All
efforts were made to avoid animal suffering and to minimize the number of
animals used.
Animals. Both adult (P80-120) and young (P20-30), C57BL/6 (Charles River
Laboratories, Como, Italy), B6.129S4-Trpv1tm1Jul/J mice (TRPV1 / ; The Jackson
Laboratory, Bar Harbor) and CX3CR1þ /GFP male mice (P18-30) from D.
Ragozzino (Sapienza University) were employed in this study.
Chronic constriction injury and testing conditions. All animals were housed in
standard cages and kept under a 12-h light–dark cycle in an air-conditioned
facility. Following the procedure originally proposed by Bennett and Xie (1988),
adapted for mice, chronic constriction injury of the sciatic nerve (CCI) was used as
murine model of neuropathic pain. CCI was obtained by three unilateral ligatures
of sciatic nerve. In the following, injured and uninjured hindpaws are indicated as
ipsilateral and contralateral hindpaws with respect to the sciatic nerve ligation.
Anesthesia was performed intraperitoneally with zoletil (tiletamine and zolazepam,
100mgml 1, 0.5ml kg 1) and rompun (xylazine, 20mgml 1, 0.5ml kg 1)67.
All mice were examined for mechanical allodynia at days 3, 5, 7, 10, 12, 14, 17,
19, 21,31 post-CCI. The behavioral test was conducted during the morning and in
blind conditions.
For ex vivo and in vitro experiments, mice were sacrificed at different time
points after CCI and the assessment of allodynia development. For adults, we used
the following time table: three days, one or four weeks after CCI, while young mice
were sacrificed at three days, one or two weeks after CCI. In particular, for
adults the mechanical threshold (force-grams) was measured in naive and CCI at
day 3, 7 and 21 after neuropathy induction (Supplementary Fig. 16).
As control, we used mice that underwent surgery without the sciatic nerve
ligature (sham animals) and naı¨ve animals, which did not undergo to any surgery.
Both in vivo and in vitro data obtained from naı¨ve and shams were pooled since no
differences have been observed. Mechanical allodynia was assessed by measuring
withdrawal threshold of both hindpaws to normally non-noxious punctuate
mechanical stimuli by using an automatic von Frey apparatus (Dynamic Plantar
Aesthesiometer, Ugo Basile, Comerio, Italy). After a 5min of adaptation to the
apparatus, the mechanical stimulus was applied to the midplantar surface of both
hindpaws. The mechanical threshold was measured as the maximal force
(expressed in grams) at which mice withdrew its hindpaw. At each testing day,
withdrawal threshold were taken as mean of three consecutive measurements with
10-s interval between each measurement.
Electrophysiological recordings from neurons. Both naı¨ve/sham and CCI adult
C57BL6 and TRPV1 KO mice were deeply anesthetized with isofluorane
inhalation, decapitated, and brains removed and immersed in cold ‘cutting’
solution (4 C) containing (in mM): 126 choline, 11 glucose, 26 NaHCO3, 2.5 KCl,
1.25 NaH2PO4, 10 MgSO4, 0.5 CaCl2 equilibrate with 95% O2 and 5% CO2.
Coronal slices (300 mm) were cut with a vibratome (Leica) and then incubated in
oxygenated artificial cerebrospinal fluid (ACSF) containing (in mM): 126 NaCl, 26
NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2 and 10 glucose; pH 7.4,
initially at 32 C for one hour, and subsequently at room temperature, before
being transferred to the recording chamber and maintained at 32 C. Recordings
were obtained from visually identified pyramidal neurons in layer 2/3, easily
distinguished by the presence of an emerging apical dendrite. Experiments were
performed in the whole-cell configuration of the patch-clamp technique. Electrodes
(tip resistance¼ 3–4MO) were filled with an intracellular solution containing
(in mM): Kgluconate 135, KCl 4, NaCl 2, HEPES 10, EGTA 4, MgATP 4 NaGTP 2;
pH adjusted to 7.3 with KOH; 290 mOsm. Whole-cell voltage-clamp recordings
( 70mV holding potential) were obtained using a Muticlamp 700B (Axon CNS,
Molecular Device). Spontaneous EPSCs recorded in the presence of tetrodotoxin
(TTX; 1 mM) (mEPSCs) were filtered at 1 kHz, digitized at 10 kHz, and recorded on
computer using Digidata1440A and pClamp10 software (Molecular Device). Series
resistances were not compensated to maintain the highest possible signal-to noise
and were monitored throughout the experiment. Recordings were discarded if Rs
changed 25% of its initial value. Experiments in voltage-clamp recording were
carried out in the presence of GABAA receptor antagonist picrotoxin (100 mM) and
TTX (1mM). Spontaneous events were detected and analysed with Clampfit 10.4
using amplitude and area thresholds set as a multiple (3–4X) of the SD of the
noise. Each event was also visually inspected to prevent noise disturbance of
the analysis. The cumulative amplitude and interevent plots obtained for
each cell in controls and after drug application were compared using the
Kolmogorov–Smirnov (KS) test.
Each slice received only a single exposure to capsaicin or to other agonists. In
experiments performed to investigate a postsynaptic TRPV1-mediated response,
the ionotropic glutamate receptor blockers 6,7-dinitroquinoxaline-2,3,dione
(DNQX, 10mM) and DL-2-amino-5-posphonovaleric acid (DL-APV, 50 mM) and
the GABAA receptor antagonist picrotoxin (100 mM) were included in the bath
solutions. For voltage-clamp experiments TTX were also added.
For current-clamp experiments membrane resistance was measured from
responses to current injections ( 60 pA, 250 ms, 0.2Hz) and were performed in
the presence of ionotropic glutamatergic and GABAA receptor antagonists.
Electrophysiological recordings from microglia cells. Acute slice of cingulate
cortex (cG1 and cG2) was prepared from CX3CR1þ /GFP male mice (P18-30).
Animals were decapitated under halothane anesthesia, and whole brains were
rapidly immersed for 10min in chilled standard artificial cerebrospinal fluid
(ACSF) containing (in mM): NaCl 125, KCl 2.3, CaCl2 2, MgCl2 1, NaHPO4 1,
NaHCO3 26 and glucose 10 (Sigma Aldrich). The ACSF was continuously
oxygenated with 95% O2, 5% CO2 to maintain physiological pH. Coronal 250mm
cingulate cortex slices were cut at 4 C with a vibratome (DSK, Kyoto, Japan)
and placed in a chamber containing oxygenated ACSF to recover for at least
1 h at room temperature.
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All recordings were performed on slices submerged in warmed ACSF
(30–32 C) and perfused (1mlmin 1) with the same solution in the recording
chamber under the microscope.
Visually identified GFP-expressing microglial cells were patched in whole-cell
configuration in the cingulate cortex. Micropipettes (4–5MO) were usually filled
with solution containing the following composition (in mM): KCl 140, EGTA 0.5,
MgCl2 2, HEPES 10, and Mg-ATP 2 (pH 7.3 adjusted with KOH, osmolarity 290
mOsm; Sigma Aldrich). Voltage-clamp recordings were performed using an
Axopatch 200A amplifier (Molecular Devices). Currents were filtered at 2 kHz,
digitized (10 kHz) and collected using Clampex 10 (Molecular Devices); the
analysis was performed off-line using Clampfit 10 (Molecular Devices). Slicing
procedure might activate microglial cells especially near the surface of the slice,
whereby recordings were performed on deep cells. The current/voltage (I/V)
relationship of each cell was determined applying ramp protocol from -120 to
þ 50mV in 500 msec every 10–30 s after whole-cell configuration was achieved
(HP¼  70mV between steps). Resting membrane potential and membrane
capacitance were measured at start of recording.
Capsaicin was first dissolved in DMSO and then in ACSF solution at a final
concentration of 1 mM and applied in bath for 3–10min.
One to four cells per mice were recorded. At least four animals per group
were used.
Immunofluorescence from fixed cortex, spinal cord and dorsal root ganglion.
Both young (P21-24) and adult (P80-90) naı¨ve and CCI C57BL6J/Trpv1 / mice
were sacrificed with lethal dose of carbon dioxide and immediately underwent
perfusion procedure. Blood was firstly transcardially washed out with cold phos-
phate buffer 0.9% saline solution (PBS), and tissues were fixed by cold 4% para-
phormaldehyde in 0.1 M pH 7.4 phosphate buffer (PB) with a peristaltic pump.
Brains and spinal cords were dissected, postfixed for 18–22 h at 4 C, washed from
paraphormaldehyde with PB and cryoprotected in 30% sucrose/PB at 4 C.
Dry ice frozen brains were cut into 40 mm coronal sections with a cryostat
microtome (Leica Microsystems) at  20 C, including anterior cingulated cortex
(ACC, Figs 22–28 of mouse brain atlas, Franklin e Paxinos, 2001). Frozen lumbar
spinal cord (L4-L5) was cut into 40 mm sections. Dorsal root ganglia were dissected
from not perfused animals, fixed by 4% paraphormaldehyde solution,
cryoprotected in sucrose solution and cut in 30 mm sections.
Sections were rinsed for tree time in PB and incubated with a mix of primary
antibodies in PB 0.3% Triton X-100 (Applichem, BioChemica, Darmstadt,
Germany) overnight at room temperature. Primary antibody incubation step was
followed by three 10-min rinses in PB at RT. Afterwards, sections were incubated
for 2 h at RT in a mix of secondary antibodies, followed by three 10-min rinses in
PB. DAPI was applied for 5min in the second rinse, dissolved in PB solution.
To exclude non-specific signals of secondary antibodies, sections from each
group of animals have also been stained with secondary antibody alone, following
the same experimental procedure but omitting the primary antibodies.
Two or three cortical sections per mice were analysed and ‘n’ represents the
number of mice used for each experiment.
Histology and immunofluorescence from fresh cortical slices. Adult (P80-90)
C57BL6 and B6.129S4-Trpv1tm1Jul/J (TRPV1 / ) mice were sacrificed after
anesthesia with isoflurane and the brain was immediately dissected. 300 mm
thickness coronal slices containing ACC were cut with a vibratome (Leica
Microsystems) in oxygenated ACSF. Slices were then kept at 32 C in a submerged
chamber containing ACSF equilibrated with a mixture of 5% CO2 and 95% O2. For
the pharmacological treatments, slices were transferred in a submerged chamber
containing ACSF (control), ACSF plus DMSO (vehicle), capsaicin (1 mM) or LPS
(500 ngml 1) for 10min (same time as used for electrophysiological recordings)
and immediately after, fixed in 4% paraphormaldehyde,0.1M phosphate buffer
(PB) for 2 h at room temperature. After the fixing, slices were cryoprotected
in 30% sucrose/PB and resectioned into 40 mm coronal sections with a cryostat
microtome, following the same procedure as for fixed slices.
Antibodies. The following primary antibodies were used: rabbit anti-TRPV1
(1:100, AB800-85 Immunological Sciences Rome, Italy), mouse anti-TRPV1
(1:100, 1:1,000 in western blot assays, MAB5568 Millipore Bioscience Research
Reagents, USA), rabbit anti-TRPV1 (1:500, RA14113 Neuromics, Edina, MN),
rabbit or mouse anti-NeuN (1:1,000, 1:500 in WB assays ABN78/MAB377
Millipore Bioscience Research Reagents, USA), rabbit anti-Neurofilament 200
(NF200 1:300, N4142 Sigma Aldrich, St Louis, USA), rabbit anti-Calcitonin Gene
Related Peptide (CGRP 1:300, PC205L Millipore Bioscience Research Reagent,
USA), guinea pig anti-glial glutamate transporter-1 (EAAT2, GLT1 1:300, AB1783
Millipore Bioscience Research Reagents, USA), rabbit anti-Glast (EAAT1 1:1,200,
AB85863 Abcam, Cambridge, UK ), goat anti-neuronal Glutamate Transporter
(EAAC1 1:100, AB1520 Millipore Bioscience Research Reagents, USA), rabbit
anti-Glutamate Decarboxylase 65&67 (1:300 AB1511 Millipore Bioscience
Research Reagents, USA), rabbit anti-CAMKII (1:300 AB52476 Abcam,
Cambridge, UK), Isolectin IB4 Biotin conjugates (IB4 1:200, I21414 ThermoFisher
Scientific, MA, USA), rabbit anti-Iba1 (1:500 in both IF and WB assays, 019-19741
Wako, Osaka, Japan), rat anti-CD11b (1:200, MCA711 Serotec; Kidlington, UK),
goat anti-Glutamate Transporter (EAAC1, 1:100, AB1520 Millipore Bioscience
Research Reagents, USA). For nuclear staining, 4,60 diamidino2-phenylindole
dihydrochloride (DAPI,1:2,000, D1306 Life Technologies, Carlsbad, California)
was used.
Secondary Cy3, DyLight488 and DyLight 649-conjugated antibodies were used
(1:200, Jackson ImmunoResearch, West Grove, PA, USA).
Acquisition and analysis of images. Double-immunofluorescence and
triple-fluorescence labelling was examined with a confocal laser scanning
microscope (Leica SP5, Leica Microsystems, Wetzlar, Germany) equipped with
four laser lines: violet diode emitting at 405 nm, argon emitting at 488 nm, and
helium/neon emitting at 543 nm and 633. Confocal images were acquired through
the 40 /63 objective at the 1 zoom factor. In the case of magnifications, zoom
factor was raised to focus only on the area of interest.
Points of colocalization were supposed when a merging area in the same
cell was evident, showing a yellow resulting colour from the overlap of two
green-red signals, and they were verified by magnifications and analysis on
the z axes with 1–2 microns stacks.
Quantitative data from images were obtained keeping the following image
acquisition criteria: 40 objective, 1024 1024 frame, 10 hz acquisition frequency,
pinhole 1 airy unit, lasers at 50%.
For analysis of the area occupied by the signal, confocal acquisitions of ACC for
each hemisphere were taken comprehending area covered by the 40x objective in
both naı¨ve and mice suffering from neuropathic pain (two for ipsilateral and two
for contralateral ACC), to have an overview of the first cortical layers (layers 2–3),
and a second acquisition including the more internal layers (layer five). Since there
were no significant differences between medial and internal layers (measured for
each couple of layers for any group, t Test P40.05), quantifications were
cumulated so as to obtain an evaluation of the antibody expression in the whole
ACC.
Each image has been analysed with Image J free software (National Institutes of
Health, US; http://imagej.nih.gov/) with the following procedure: for each single
image the background was subtracted in a same proportion for each group, in
a range between 10–50% on respect to the specific antibody. Images were reduced
at 8 bit from the original RGB acquisition and a threshold was established to
obtain a digital image where neither original signal disappeared and nor new signal
was created. These images were analysed with the command ‘analysis of particles’,
setting a filter to the size of signal and measuring in micrometers. Data were
expressed as Area Fraction, the percentage of the total image area covered by the
measured object. To establish the percentage of neurons expressing TRPV1, or
both TRPV1 and EAAC1 marker, images in double and triple staining were
acquired. Cells immunopositive for NeuN, TRPV1 and EAAC1 were counted,
in the merging images, by the use of non-automatic cell counting method
(Leica Microsystems software). Data are presented as the percentage of means.
Colocalization was intended as two proteins that occupy the same volume of
interest.
The amount of colocalization was evaluated by using the Pearson statistical
index of correlation (r) between two variables. This analysis describes the effect size
as the strength of the linear correlation between the two variables (Evans,34: 0–0.19
‘very weak’, 0.20–0.39 ‘weak’, 0.40–0.59 ‘moderate’, 0.60–0.79 ‘strong’, 0.80–1.0
‘very strong’).
For colocalization analysis, a double fluorescence image (red and green dyes)
was splitted in RedGreenBlu channels. Background was subtracted from the red
and the green channels (8 bit each) and they were analysed for correlation using the
colocalization plugin with Pearson and Manders index. Pearson index was chosen
for its consistency and lack of sensibility to the picture background.
For each colocalization analysis, 256 256 Red-green scatterplots were
generated by the Image J program: the intensity of red pixels is used as the
x-coordinate whereas the intensity of the green pixels as the y-coordinate.
Morphometric analyses. Morphometric analysis were performed on a high
resolution image acquisition criteria: 40 objective, 2048 2048 frame, 200 hz
acquisition frequency 3X average scan, pinhole 1 airy unit, lasers at 50%.
Although two 40x objective confocal acquisitions were acquired to obtain an
overview of ACC (one for cortex layers 2/3 and one for layer five) only the first
layers acquisition (L2/3) was chosen for morphometrical analysis.
Each image has been analysed with plugin ‘Shape descriptor 1u’ of Image J
software (http://imagej.nih.gov/plugins) with the following procedure: images were
reduced at 8 bit from the original RGB acquisition and a threshold was established
to obtain a digital image where neither the original signal disappeared and nor new
signal was created. The plugin setting was fixed at a minimum of 200mm of size
and analysis was performed automatically on cell silhouettes.
Transformation index (TI) was used as an index of microglia morphology86,87
and calculated by the equation: [perimeter of cell (mm)]2/4P [cell area (mm2)].
Since TI is dependent on cell shape but independent of cell size, this latter crucial
for the identification of the three different microglia activation states (bushy,
hypertrophied and ameboid), we exploit this parameter to obtain an unbiased
analyses and avoid negative falses. The area/TI ratio was calculated for each cell
and a scale value was set to obtain 4 group of cells (Supplementary Fig. 1a):
RESTING cells (values of area:TI ranging from 1 to 25); HYPERTROPHIED cells
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(values of area/TI ranging from 25 to 35); BUSHY cells (values of area/TI ranging
from 35 to 60); AMEBOID cells (values of area/TI up of 60). The percentage of cell
ratio was calculated by dividing the number of a specific cell group (i.e., resting,
bushy, hypertrophied and amoeboid) for the total cell number of each experimental
condition (control, vehicle, capsaicin/lps, in both wt and TRPV1 / tissue).
The frequency of cells in each category was statistically quantified by the using
of Fisher’s exact test and performed on raw data.
Western blotting. Western blotting was performed according to standard
procedures. Briefly, isolated tissues (10mg) and cells (3 105) were resuspended in
lysis buffer (50mM Tris-HCl, pH 7.4, 150mM NaCl, 5mM MgCl2, 1mM EGTA,
1% (v/v) Nonidet P-40, 10mgml 1 aprotinin, 10 mgml 1 leupeptin, 1mM PMSF),
homogenized with a glass-Teflon homogenizer and/or sonicated before
centrifugation. Proteins in the lysates were quantified by the Bradford assay
kit (Bio-Rad, Hercules, CA, USA), separated by SDS-PAGE (10%) and transferred
to nitrocellulose membranes. Blots were then incubated with primary antibodies
recognizing TRPV1 (diluted 1:1,000), NeuN (diluted 1:500), Iba1 (1:500), or
actin (diluted 1:100,000). After incubation with the appropriate horseradish
peroxidase-conjugated antibody, blots were developed using an enhanced chemi-
luminescence detection system (Luminata Crescendo Western HRP substrate,
Merck Millipore, Darmstadt, Germany). Scanning densitometry on the developed
film was conducted at 600 dpi using a CanoScan LiDE 210 (Canon, Tokyo, Japan)
and analysed using Image J 1.49v program (http://imagej.nih.gov/ij).
Images have been cropped for presentation. Full-size images are presents in
Supplementary Fig. 18.
Isolation of neuronal and microglial cells and flow cytometry analysis.
Cerebral cortex from 26 C57Bl6J and 20 TRPV1 / mice (60–70 days old) were
dissociated to single-cell suspension by enzymatic degradation using neural tissue
dissociation kit from MACS Technology (Miltenyi Biotec) according to the man-
ufacturer’s protocol. Briefly, cortical tissues were weighed before mincing,
a pre-warmed enzyme (Papain) mix added to the tissue pieces, and incubated
under slow, continuous rotation at 37 C on a MACSMix Tube Rotator. The tissue
was further mechanically dissociated by trituration and the suspension was applied
to a 70-micron cell strainer. Myelin was removed using Myelin Removal Beads II
kit on autoMACS Pro Separator. Cells were processed immediately for MACS
MicroBead separations. To separate primary microglia, The CD11b-positive cells
were magnetically labelled with CD11b (Microglia) MicroBeads and isolated on
autoMACS Pro Separator. The negative fraction was further processed with
Neuron Isolation kit by depletion of non-neuronal cells and neurons were obtained
from the unlabelled cells running through autoMACS Pro Separator. Both cells
populations were fixed with 4% paraformaldehyde (PFA) for 10min and then
stained first with mouse primary TRPV1 antibody and then with anti-mouse
Alexa633 secondary antibody. Subsequently neuronal cells were stained with
mouse primary antibody NeuN and then with anti-mouse Alexa488 secondary
antibody, while microglial cells with PE-Cy7-conjugated CD11b. For microglial
activation experiments, 2 105 cells were left untreated or stimulated with
Capsaicin (1 mM) for 10min, washed and then left in complete medium in presence
of Brefeldin A (10 mgml 1) to block cytokine exocytosis. At the end of the
incubation, cells were stained at the cell surface with CD11b, fixed with 4% PFA
for 10min, and then stained intracellularly with APC-conjugated TNF-a and
PE-conjugated IL-10 antibodies in 0.5% saponin for 20min. Cells were acquired
using FACSCyan ADP (Beckman Coulter) flow cytometer and analysed using
Flowjo software (TreeStar, Ashland, OR, USA).
qRT-PCR. Total RNA was extracted by previously isolated mouse neurons and
microglial cells as well as from spinal cord, using ReliaprepTM RNA Cell Miniprep
System (Promega). cDNA reverse transcription was performed by means of
Superscript VILO cDNA Synthesis Kit (ThermoFisher Scientific), according to
manufacturer instructions. The following program was used for the quantitative
RT-PCR: 25 C for 10min, 42 C for 50min, 85 C for 5min, then after addition of
0.1 unit/ml of Escherichia coli RNase H, the product was incubated at 37 C for
20min. The target transcripts were amplified by means of an ABI PRISM 7700
sequence detector system (Applied Biosystems, Foster City, CA), using the
following specific primers for TRPV1 and b-actin: mouse TRPV1 F1 (50- CATCC
TCCTGCTCAACATGC-30) and R1 (50- GCCTTCCTCATGCACTTCAG-30) and
mouse b-actin F1 (50- TGTTACCAACTGGGACGA-30) and R1 (50- GTCTCAAA
CATGATCTGGGTC-30). All assays were performed in duplicate, and for each well
we used 10 ng of sample template cDNA. Assays were run on Roche Lightcycler
480 Real-Time PCR System. 20 ml assays were prepared for each sample as it
follows: 5 ml of cDNA product, 10ml of SYBR Green master mix (Roche, cat #
04707516001), 2 ml of each primer (4 mM, Sigma) and 3 ml of PCR-grade water. The
following PCR program was used: 5min of pre-incubation at 95 C, followed by 40
amplification cycles at 95 C for 10 s, 61 C for 20 s, and 72 C for 7 s. All data were
obtained using automatic detection of TRPV1 gene Ct normalized with b-actin; for
each sample, TRPV1 relative expression was evaluated as fold increase of gene
expression compared with b-actin (2^DCt, with DCt¼Ct (TPRV1) –Ct (b-actin)).
The specificity of PCR reactions was evaluated at the end of each experiment by
analyzing melting curves for each sample and, later, by running the assays in a 2%
agarose gel.
Microglia cell cultures. Primary cultures of cortical glial cells were obtained
from 2-day-old C57BL6 mice and killed by decapitation according to Directive
2010/63/EU and as describe in Levi et al. Cells were plated at low density
(3 106 cells per 90-mm dish) and cultured in basal Eagle’s medium (BME),
supplemented with 10% heat-inactivated fetal calf serum (FCS) and 5mM KCl
for 20 days. Microglial cells were obtained by dish gentle shaking, collected
by centrifugation and reseeded. This protocol produced cultures with 490%
microglial cells, as verified by immunofluorescence with monoclonal antibodies
for the specific markers ED1 and iba1.
Quantification of EVs. Nanosight measurement. Microglia were exposed to serum
free culture medium for 10min, to quantify constitutive EV production. The
medium was collected, the cells kept for about 5 h in complete medium, and then
re-exposed to serum free medium added with 300 nM capsaicin or 1mM ATP
(positive control) for 10min, to measure EV production upon TRPV1 stimulation.
Conditioned media were pre-cleared from cells and debris at 300 g for 10min
(twice) and the number and dimension of MVs and exosomes were analysed with
Nanosight LM10-HS system configured with a 405 nm laser and EMCDD
camera (Hamamatsu Photonics). Videos were collected and analysed using the
NTA-software (version 2.3), with the minimal expected particle size, minimum
track length, and blur setting, all set to automatic. Camera shutter speed was fixed
at 20.01ms and camera gain was set to 350. Ambient temperature was ranging
from 25 to 28 C. Five recordings of 30 s were performed for each sample.
EV production under capsaicin exposure was normalized to constitutive EV
release from the same Petri dishes, to minimize possible variability in the density
of donor microglia.
Spectrophotometric quantification of shed MVs. Microglia were incubated with
5mM NBD-C6_HPC, washed with Kreb’s Ringer solution, and stimulated with
ATP or capsaicin. Supernatants were collected, centrifuged 10min 300 g 4 C to
remove cells and debris, and then total fluorescence was assayed at 463/536 nm
with a Tecan Infinite500 spectrophotometric system (Tecan, Group Ltd,
Switzerland). Constitutive or evoked MV shedding was quantified from at least
three distinct Petri/condition in each experiment.
Statistics. All data were expressed as means±s.e.m. For immunofluorescence
experiments, significance was tested using one-way ANOVA followed by a Tukey
post hoc test for internal significance or student T test in the case of two groups
comparisons. For electrophysiological data, Shapiro–Wilk test was exploited to
verify a normally distributed data population. We then applied parametric or
non-parametric tests. For the former, we used ANOVA and Student t test. For
non-parametric data we used Wilcoxon Signed Rank test (paired samples) and
Mann–Whitney test and Kolmogorov Smirnov test (unpaired samples).
Statistical differences were considered as significant at Po0.05. Statistical
analysis was performed by using Origin 8.1 software (OriginLab Corporation).
Data availability. The data that support the findings of this study are available
from the corresponding author upon request.
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